GABRIELLE STEVENS: Open Payments
NPI 1386144848 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 18 payments from 9 companies in 2025. Trend: 2023 $744 · 2024 $656 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $157 |
| Merck Sharp & Dohme LLC | 4 | $133 |
| ABBVIE INC. | 4 | $112 |
| Tempus AI, Inc | 2 | $59 |
| Caris MPI, Inc. | 1 | $40 |
| Medtronic, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| LSI SOLUTIONS INC | 1 | $16 |
Products named: ELAHERE, KEYTRUDA, XT CDX, LYNPARZA, MI CANCER SEEK, TRUCLEAR, JEMPERLI, LO LOESTRIN FE.
Industry payments across GA — which companies pay providers there.
